dc.contributor.author | Slatkoff, Susan | eng |
dc.contributor.author | Gamboa, Stephen | eng |
dc.contributor.author | Zolotor, Adam J. | eng |
dc.contributor.author | Mounsey, Anne L. | eng |
dc.contributor.author | Jones, Kohar | eng |
dc.contributor.other | Family Physicians Inquiries Network | eng |
dc.date.issued | 2011 | eng |
dc.description.abstract | Do not routinely screen all men over the age of 50 for prostate cancer with the prostate-specific antigen (PSA) test. Consider screening men younger than 75 with no cardiovascular or cancer risk factors -- the only patient population for whom PSA testing appears to provide even a small benefit. Stength of recommendation: B: Based on a meta-analysis of 6 randomized controlled trials (RCTs) with methodological limitations, and a post hoc analysis of a large RCT. | eng |
dc.identifier.uri | http://hdl.handle.net/10355/10961 | |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Priority Updates to Research Literature (PURLs) (2011) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 60, no. 06 (June 2011): 357-360. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject.lcsh | Prostate -- Cancer -- Diagnosis | eng |
dc.subject.lcsh | Prostate-specific antigen | eng |
dc.subject.other | Prostate cancer | eng |
dc.subject.other | Cancer screening | eng |
dc.title | PSA testing: When it's useful, when it's not | eng |
dc.type | Article | eng |